COVID and the Courts: Expect Delay
Client Alert | 3 min read | 04.07.20
As we discussed a few weeks ago, the federal courts’ responses to COVID have varied widely. One of the most common responses across the federal courts, however, has been the extension of filing deadlines—although the particular deadlines affected and the length of the extensions granted (again) vary. To give a few examples from all levels of the federal court systems:
- The Supreme Court extended the deadline for filing a petition for certiorari from 90 days after the lower court judgment to 150 days. The Court’s extension order also noted that “motions for extensions of time . . . will ordinarily be granted by the Clerk as a matter of course if the grounds for the application are difficulties relating to COVID-19 and if the length of the extension requested is reasonable under the circumstances.”
- The Second Circuit granted a 21-day extension for all filings originally due between March 16, 2020 and May 17, 2020. However, litigants should be aware that the deadline for filing a notice of appeal and other jurisdictional deadlines have not changed.
- The Ninth Circuit has not issued blanket extensions, but the court stated that it will extend non-jurisdictional filing dates as needed. Parties may seek 60-day extensions for briefs by filing a short notice detailing the COVID-related reason for the extension. Notably, due dates for filing notices of appeal and petitions for review, as well as other jurisdictional deadlines set by statute or rule, are unaffected.
- The Northern District of Illinois extended all civil case deadlines by 39 days.
- The District of Maryland extended all filing deadlines between March 16 and April 24 by 6 weeks.
Where no blanket extension is effective, many parties have filed for significant extensions of briefing or other deadlines, citing practical impediments caused by COVID. For example, in the high-profile D.C. Circuit litigation challenging the Trump administration’s “Affordable Clean Energy Rule” (addressing greenhouse gas emission standards for power plants), in which the government had previously sought expedited review to try to have the case decided before January 2021, the petitioners sought—and the government consented to—an extension of most briefing deadlines by three weeks. Petitioners cited COVID-related “logistical challenges” including school closures and shelter-in-place orders. There also have been numerous government-initiated extension requests, with DOJ counsel similarly citing school and office closures as the justification for the extension of looming deadlines.
In short, we are seeing significant litigation delays at all levels of the federal judicial system, with the likely result of delaying the final resolution of many cases by several weeks or months. We recommend that clients with an impending litigation deadline first check to see whether the deadline is subject to an automatic extension under that particular court’s COVID-related orders; if not, we recommend clients consider requesting an extension, being candid with opposing counsel and the court about the practical problems posed by COVID-related closures.
Contacts
Insights
Client Alert | 5 min read | 12.12.25
Eleventh Circuit Hears Argument on False Claims Act Qui Tam Constitutionality
On the morning of December 12, 2025, the Eleventh Circuit heard argument in United States ex rel. Zafirov v. Florida Medical Associates, LLC, et al., No. 24-13581 (11th Cir. 2025). This case concerns the constitutionality of the False Claims Act (FCA) qui tam provisions and a groundbreaking September 2024 opinion in which the United States District Court for the Middle District of Florida held that the FCA’s qui tam provisions were unconstitutional under Article II. See United States ex rel. Zafirov v. Fla. Med. Assocs., LLC, 751 F. Supp. 3d 1293 (M.D. Fla. 2024). That decision, penned by District Judge Kathryn Kimball Mizelle, was the first success story for a legal theory that has been gaining steam ever since Justices Thomas, Barrett, and Kavanaugh indicated they would be willing to consider arguments about the constitutionality of the qui tam provisions in U.S. ex rel. Polansky v. Exec. Health Res., 599 U.S. 419 (2023). In her opinion, Judge Mizelle held (1) qui tam relators are officers of the U.S. who must be appointed under the Appointments Clause; and (2) historical practice treating qui tam and similar relators as less than “officers” for constitutional purposes was not enough to save the qui tam provisions from the fundamental Article II infirmity the court identified. That ruling was appealed and, after full briefing, including by the government and a bevy of amici, the litigants stepped up to the plate this morning for oral argument.
Client Alert | 8 min read | 12.11.25
Director Squires Revamps the Workings of the U.S. Patent Office
Client Alert | 8 min read | 12.10.25
Creativity You Can Use: CJEU Clarifies Copyright for Applied Art
Client Alert | 4 min read | 12.10.25
Federal Court Strikes Down Interior Order Suspending Wind Energy Development




